Who we help accelerate
Accelerate the scale up of your genetic testing & unlock the value in your data.
NGS Assay & Equipment Manufacturers
Bring new tests to market and scale up testing fast.
Accelerate your research breakgthroughs and novel drug launches.
Non-Profits and Government Agencies
Accelerate your research breakthroughs and unlock the value in your data.
How we can help
Clinical Interpretation & Reporting
Secondary & Tertiary analytics tools enabled by expert clinical services.
Effectively navigate and grow in the changing regulatory environment.
NGS Assay Development & Expansion
Bring new tests to market and scale-up fast.
Companion Diagnostic Development & Scaling
Develop better diagnostics that scale faster, accelerating novel drug uptake.
Harmonize and augment your data to unlock the value within.
Use cutting edge technology to make new discoveries and breakthroughs faster.
Our cutting-edge technology suite
Our tertiary analytics & reporting tool for clinical NGS diagnostics.
Our best in class, IVD-grade variant interpretation knowledge base.
Our Trusted Research Environment (TRE) for bioinformatic analysis & pipeline development.
Our data harmonization and secure sharing platform.
Our award winning reference genome tool.
High throughput for PCR made simple.
Our in-house expert teams
Supporting diagnostic labs to start and scale-up their NGS testing.
Supporting clinical diagnostic labs and diagnostic test developers to navigate the changing regulatory environment.
Supporting health & life science companies to combine and harmonize their data.
Supporting researchers and diagnostic developers to build better workflows.
Supporting researchers to run efficient and effective studies.
Our company
Publications, whitepapers, webinars, videos, and more.
The latest from the precision medicine experts at Velsera.
Interested in joining the team? Explore careers here.
Visit our legal section for all of the details.
Home | Get a Demo
And neither do you. Schedule a demo today.
What to expect:
Our team will customize the demo to address your specific needs and challenges.
Witness our solutions in action as we guide you through key features and functionalities.
Have questions? We're here to provide clarity and insights to help you make informed decisions.
Interpreting large-scale, complex transcriptomics data is critically important for understanding the molecular and cellular basis of disease. We are confident that by working with the unique multi-cloud technology developed by Velsera and by benefiting from the depth and breadth of their expertise in bioinformatics and cloud computing, these solutions will assist us in maximizing the value of the data we generate.
”Pharma Leader
Vice President, Medicinal Sciences / Top 10 Global Biopharmaceutical Company
There's going to be a bottleneck in the professional component as well sometimes. Velsera allowed us to widen that bottleneck and to have more uniformity of reporting.
”Eric Loo, MD
Asst. Professor, Pathology and Lab Medicine / Dartmouth-Hitchcock Health
The Clinical Genomics Workspace (CGW) by Velsera has provided our laboratory with a seamless, integrated software solution that allows us to spend more time analyzing the sequencing data and generating clinical reports and less time worrying about logistics.
”James Patrick Solomon, M.D., Ph.D.
Medical Director, Clinical Genomics Laboratory / Weill Cornell Medicine
We are in a race against time to find better therapies so that all patients with pancreatic cancer have the opportunity to thrive, and we are confident that large-scale, multi-omics projects will provide us the data that will speed progress. Our research platform features a custom interface that was purpose-built to the needs of our researchers and supports our rich data models and data integrations. This interface was built on top of ARIA, and we are grateful for the exploration and search capabilities it provides for users.
”Velsera has been a great partner enabling our NGS offering so we can improve the quality and speed of patient care. With Velsera's team and technology, we have been able to streamline our workflow and customize our clinical report. We can run various assays using the single Velsera platform. And our physicians are highly complementary of the report we created with Velsera given the content and aesthetic.
”Jen Gass
Associate Director, Genetics Laboratory / Florida Cancer Specialists
I knew that with the resources we had, there was no way to create something that would rival a system like the CGW. As we've set up reflex testing in various cancer types, we have been well supported to scale the massive undertaking.
”Nikoletta Sidiropoulos, MD
Medical Director / University of Vermont Medical Center
Using standard computational tools, we are already finding a large number of novel variants of African and Native American ancestries within the Brazilian genomes. We want to use the graph-based approach in order to capture the full value of our genomes.
”